Federal regulators are working on a stronger label for a widely used diabetes drug, Byetta, after deaths continue to be reported despite earlier government warnings.
Federal regulators are working on a stronger label for a widely used diabetes drug, Byetta, after deaths continue to be reported despite earlier government warnings.